Melagatran

DB13616InvestigationalSmall molecule

Melagatran: Overview.

Chemical structure of Melagatran
Formula / weight
C22H31N5O4 · 429.5126 g/mol (avg)

Resolves to

Compound
UNII2A9QP32MD4CAS159776-70-2ChEMBLCHEMBL266349ChEBI43966KEGGD07143
Clinical / RWD
ATCB01AE04
Structure
InChIKeyDKWNMCUOEDMMIN-PKOBYXMFSA-NSMILES[H][C@]1(CCN1C(=O)[C@H](NCC(O)=O)C1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
Targets
P00742F10P07477PRSS1P00747PLGP00734F2

What you can answer from here — as of March 06, 2025

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
37Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
13+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Melagatran, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In